Lv51
1430 积分 2022-03-29 加入
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
4小时前
待确认
Comparison of the effectiveness of alectinib versus crizotinib followed by alectinib in patients with ALK-positive advanced non-small-cell lung cancer in real-world setting and in the ALEX study
3个月前
已关闭
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
1年前
已完结
Effects and risk factors of TAS-102 in real-worldpatients with metastatic colorectal cancer, EROTASR study
1年前
已完结
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
1年前
已完结
Effects and risk factors of TAS-102 in real-world patients with metastatic colorectal cancer, EROTAS-R study
2年前
已完结
Analysis of neutropenia as a predictive factor of the efficacy of trifluridine-tipiracil treatment
2年前
已关闭
Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990-2019
2年前
已完结
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
2年前
已完结
Combination Therapy, Including Bevacizumab, for Advanced Colorectal Cancer
2年前
已完结
The ars Operon in the skin Element of Bacillus subtilis Confers Resistance to Arsenate and Arsenite
3年前
已采纳
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
3年前
已驳回
Fundamentals of Inkjet Printing
3年前
已采纳
Diverse emission properties of transition metal complexes beyond exclusive single phosphorescence and their wide applications
3年前
已采纳
Potassium-assisted carbonization of chlorobenzene in Ar/H2 to prepare porous carbon with low oxygen content for high withstanding voltage EDLCs
3年前
已采纳
Tannin-derived micro-mesoporous carbons prepared by one-step activation with potassium oxalate and CO2
3年前
已采纳
Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience
3年前
已采纳
皖公网安备34019202002308
